[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Aurora Kinase C Market Research Report 2018

February 2018 | 99 pages | ID: C4B05557A57EN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Aurora Kinase C market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Aurora Kinase C development status and future trend in China, focuses on top players in China, also splits Aurora Kinase C by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • AbbVie Inc
  • Amgen Inc
  • Cielo Therapeutics Inc
  • Sanofi

Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
  • AMG-900
  • Danusertib
  • Ilorasertib
  • NMI-900
  • SAR-156497
  • Others
On the basis of the end users/application, this report covers
  • Solid Tumor
  • Non-Small Cell Lung Cancer
  • Acute Lymphocytic Leukemia
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Aurora Kinase C Market Research Report 2017

1 AURORA KINASE C OVERVIEW

1.1 Product Overview and Scope of Aurora Kinase C
1.2 Classification of Aurora Kinase C by Product Category
  1.2.1 China Aurora Kinase C Sales (K Pcs) Comparison by Type (2012-2022)
  1.2.2 China Aurora Kinase C Sales (K Pcs) Market Share by Type in 2016
  1.2.3 AMG-900
  1.2.4 Danusertib
  1.2.5 Ilorasertib
  1.2.6 NMI-900
  1.2.7 SAR-156497
  1.2.8 Others
1.3 China Aurora Kinase C Market by Application/End Users
  1.3.1 China Aurora Kinase C Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Solid Tumor
  1.3.3 Non-Small Cell Lung Cancer
  1.3.4 Acute Lymphocytic Leukemia
  1.3.5 Others
1.4 China Aurora Kinase C Market by Region
  1.4.1 China Aurora Kinase C Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Aurora Kinase C Status and Prospect (2012-2022)
  1.4.3 East China Aurora Kinase C Status and Prospect (2012-2022)
  1.4.4 Southwest China Aurora Kinase C Status and Prospect (2012-2022)
  1.4.5 Northeast China Aurora Kinase C Status and Prospect (2012-2022)
  1.4.6 North China Aurora Kinase C Status and Prospect (2012-2022)
  1.4.7 Central China Aurora Kinase C Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Aurora Kinase C (2012-2022)
  1.5.1 China Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2022)
  1.5.2 China Aurora Kinase C Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA AURORA KINASE C MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Aurora Kinase C Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Aurora Kinase C Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Aurora Kinase C Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
2.4 China Aurora Kinase C Market Competitive Situation and Trends
  2.4.1 China Aurora Kinase C Market Concentration Rate
  2.4.2 China Aurora Kinase C Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Aurora Kinase C Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA AURORA KINASE C SALES AND REVENUE BY REGION (2012-2017)

3.1 China Aurora Kinase C Sales (K Pcs) and Market Share by Region (2012-2017)
3.2 China Aurora Kinase C Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Aurora Kinase C Price (USD/Pcs) by Regions (2012-2017)

4 CHINA AURORA KINASE C SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Aurora Kinase C Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
4.2 China Aurora Kinase C Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Aurora Kinase C Price (USD/Pcs) by Type (2012-2017)
4.4 China Aurora Kinase C Sales Growth Rate (%) by Type (2012-2017)

5 CHINA AURORA KINASE C SALES BY APPLICATION (2012-2017)

5.1 China Aurora Kinase C Sales (K Pcs) and Market Share by Application (2012-2017)
5.2 China Aurora Kinase C Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA AURORA KINASE C PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Aurora Kinase C Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Aurora Kinase C Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cielo Therapeutics Inc
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Aurora Kinase C Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cielo Therapeutics Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Aurora Kinase C Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview

7 AURORA KINASE C MANUFACTURING COST ANALYSIS

7.1 Aurora Kinase C Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Aurora Kinase C

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Aurora Kinase C Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Aurora Kinase C Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA AURORA KINASE C MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Aurora Kinase C Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
11.2 China Aurora Kinase C Sales (K Pcs) Forecast by Type (2017-2022)
11.3 China Aurora Kinase C Sales (K Pcs) Forecast by Application (2017-2022)
11.4 China Aurora Kinase C Sales (K Pcs) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Aurora Kinase C Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Aurora Kinase C Sales (K Pcs) by Application (2016-2022)
Figure Product Picture of Aurora Kinase C
Table China Aurora Kinase C Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Aurora Kinase C Sales Volume Market Share by Types in 2016
Figure AMG-900 Product Picture
Figure Danusertib Product Picture
Figure Ilorasertib Product Picture
Figure NMI-900 Product Picture
Figure SAR-156497 Product Picture
Figure Others Product Picture
Figure China Aurora Kinase C Sales (K Pcs) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Aurora Kinase C by Application in 2016
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Non-Small Cell Lung Cancer Examples
Table Key Downstream Customer in Non-Small Cell Lung Cancer
Figure Acute Lymphocytic Leukemia Examples
Table Key Downstream Customer in Acute Lymphocytic Leukemia
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Aurora Kinase C Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2022)
Figure China Aurora Kinase C Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Aurora Kinase C Sales of Key Players/Manufacturers (2012-2017)
Table China Aurora Kinase C Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Aurora Kinase C Sales Share (%) by Players/Manufacturers
Figure 2017 China Aurora Kinase C Sales Share (%) by Players/Manufacturers
Table China Aurora Kinase C Revenue by Players/Manufacturers (2012-2017)
Table China Aurora Kinase C Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Aurora Kinase C Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Aurora Kinase C Revenue Market Share (%) by Players/Manufacturers
Table China Market Aurora Kinase C Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Aurora Kinase C Average Price of Key Players/Manufacturers in 2016
Figure China Aurora Kinase C Market Share of Top 3 Players/Manufacturers
Figure China Aurora Kinase C Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Aurora Kinase C Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Aurora Kinase C Product Category
Table China Aurora Kinase C Sales (K Pcs) by Regions (2012-2017)
Table China Aurora Kinase C Sales Share (%) by Regions (2012-2017)
Figure China Aurora Kinase C Sales Share (%) by Regions (2012-2017)
Figure China Aurora Kinase C Sales Market Share (%) by Regions in 2016
Table China Aurora Kinase C Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Aurora Kinase C Revenue Market Share (%) by Regions (2012-2017)
Figure China Aurora Kinase C Revenue Market Share (%) by Regions (2012-2017)
Figure China Aurora Kinase C Revenue Market Share (%) by Regions in 2016
Table China Aurora Kinase C Price (USD/Pcs) by Regions (2012-2017)
Table China Aurora Kinase C Sales (K Pcs) by Type (2012-2017)
Table China Aurora Kinase C Sales Share (%) by Type (2012-2017)
Figure China Aurora Kinase C Sales Share (%) by Type (2012-2017)
Figure China Aurora Kinase C Sales Market Share (%) by Type in 2016
Table China Aurora Kinase C Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Aurora Kinase C Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase C by Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase C by Type in 2016
Table China Aurora Kinase C Price (USD/Pcs) by Types (2012-2017)
Figure China Aurora Kinase C Sales Growth Rate (%) by Type (2012-2017)
Table China Aurora Kinase C Sales (K Pcs) by Applications (2012-2017)
Table China Aurora Kinase C Sales Market Share (%) by Applications (2012-2017)
Figure China Aurora Kinase C Sales Market Share (%) by Application (2012-2017)
Figure China Aurora Kinase C Sales Market Share (%) by Application in 2016
Table China Aurora Kinase C Sales Growth Rate (%) by Application (2012-2017)
Figure China Aurora Kinase C Sales Growth Rate (%) by Application (2012-2017)
Table AbbVie Inc Aurora Kinase C Basic Information List
Table AbbVie Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure AbbVie Inc Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure AbbVie Inc Aurora Kinase C Sales Market Share (%) in China (2012-2017)
Figure AbbVie Inc Aurora Kinase C Revenue Market Share (%) in China (2012-2017)
Table Amgen Inc Aurora Kinase C Basic Information List
Table Amgen Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Amgen Inc Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Amgen Inc Aurora Kinase C Sales Market Share (%) in China (2012-2017)
Figure Amgen Inc Aurora Kinase C Revenue Market Share (%) in China (2012-2017)
Table Cielo Therapeutics Inc Aurora Kinase C Basic Information List
Table Cielo Therapeutics Inc Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase C Sales Market Share (%) in China (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase C Revenue Market Share (%) in China (2012-2017)
Table Sanofi Aurora Kinase C Basic Information List
Table Sanofi Aurora Kinase C Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
Figure Sanofi Aurora Kinase C Sales (K Pcs) and Growth Rate (%)(2012-2017)
Figure Sanofi Aurora Kinase C Sales Market Share (%) in China (2012-2017)
Figure Sanofi Aurora Kinase C Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Aurora Kinase C
Figure Manufacturing Process Analysis of Aurora Kinase C
Figure Aurora Kinase C Industrial Chain Analysis
Table Raw Materials Sources of Aurora Kinase C Major Players/Manufacturers in 2016
Table Major Buyers of Aurora Kinase C
Table Distributors/Traders List
Figure China Aurora Kinase C Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022)
Figure China Aurora Kinase C Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Aurora Kinase C Price (USD/Pcs) Trend Forecast (2017-2022)
Table China Aurora Kinase C Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Aurora Kinase C Sales (K Pcs) Forecast by Type (2017-2022)
Figure China Aurora Kinase C Sales Volume Market Share Forecast by Type in 2022
Table China Aurora Kinase C Sales (K Pcs) Forecast by Application (2017-2022)
Figure China Aurora Kinase C Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Aurora Kinase C Sales Volume Market Share Forecast by Application in 2022
Table China Aurora Kinase C Sales (K Pcs) Forecast by Regions (2017-2022)
Table China Aurora Kinase C Sales Volume Share Forecast by Regions (2017-2022)
Figure China Aurora Kinase C Sales Volume Share Forecast by Regions (2017-2022)
Figure China Aurora Kinase C Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications